132 related articles for article (PubMed ID: 37028200)
1. Association between objective neurocognitive functioning and neurocognitive complaints in recurrent high-grade glioma: Longitudinal evidence of cognitive awareness from EORTC brain tumour trials.
Caramanna I; Reijneveld JC; van de Ven PM; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Klein M;
Eur J Cancer; 2023 Jun; 186():38-51. PubMed ID: 37028200
[TBL] [Abstract][Full Text] [Related]
2. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
[TBL] [Abstract][Full Text] [Related]
3. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a systematic review of neurocognitive functioning prior to anti-tumor treatment.
van Kessel E; Baumfalk AE; van Zandvoort MJE; Robe PA; Snijders TJ
J Neurooncol; 2017 Aug; 134(1):9-18. PubMed ID: 28567586
[TBL] [Abstract][Full Text] [Related]
4. Neurocognitive changes after awake surgery in glioma patients: a retrospective cohort study.
van Kessel E; Snijders TJ; Baumfalk AE; Ruis C; van Baarsen KM; Broekman ML; van Zandvoort MJE; Robe PA
J Neurooncol; 2020 Jan; 146(1):97-109. PubMed ID: 31802314
[TBL] [Abstract][Full Text] [Related]
5. Association between tumor location and neurocognitive functioning using tumor localization maps.
Habets EJJ; Hendriks EJ; Taphoorn MJB; Douw L; Zwinderman AH; Vandertop WP; Barkhof F; De Witt Hamer PC; Klein M
J Neurooncol; 2019 Sep; 144(3):573-582. PubMed ID: 31410731
[TBL] [Abstract][Full Text] [Related]
6. Assessment of neurocognitive function in association with WHO grades in gliomas.
Yamawaki R; Nankaku M; Umaba C; Ueda M; Liang N; Mineharu Y; Yamao Y; Ikeguchi R; Matsuda S; Miyamoto S; Arakawa Y
Clin Neurol Neurosurg; 2021 Sep; 208():106824. PubMed ID: 34329808
[TBL] [Abstract][Full Text] [Related]
7. "A prospective study of assessment of neurocognitive function in illiterate patients with gliomas treated with chemoradiation": Assessment of neurocognitive function in gliomas.
Valiyaveettil D; G A; Malik M; Eaga P; Ahmed SF; Joseph D
Cancer Treat Res Commun; 2021; 26():100288. PubMed ID: 33352469
[TBL] [Abstract][Full Text] [Related]
8. Impact of neurocognitive deficits on patient-proxy agreement regarding health-related quality of life in low-grade glioma patients.
Ediebah DE; Reijneveld JC; Taphoorn MJ; Coens C; Zikos E; Aaronson NK; Heimans JJ; Bottomley A; Klein M;
Qual Life Res; 2017 Apr; 26(4):869-880. PubMed ID: 27744512
[TBL] [Abstract][Full Text] [Related]
9. Tumor-related neurocognitive dysfunction in patients with diffuse glioma: a retrospective cohort study prior to antitumor treatment.
van Kessel E; Emons MAC; Wajer IH; van Baarsen KM; Broekman ML; Robe PA; Snijders TJ; Van Zandvoort MJE
Neurooncol Pract; 2019 Dec; 6(6):463-472. PubMed ID: 31832216
[TBL] [Abstract][Full Text] [Related]
10. Relationship between neurocognitive function and quality of life after whole-brain radiotherapy in patients with brain metastasis.
Li J; Bentzen SM; Li J; Renschler M; Mehta MP
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):64-70. PubMed ID: 18406884
[TBL] [Abstract][Full Text] [Related]
11. Long-term neurocognitive and other side effects of radiotherapy, with or without chemotherapy, for glioma.
Lawrie TA; Gillespie D; Dowswell T; Evans J; Erridge S; Vale L; Kernohan A; Grant R
Cochrane Database Syst Rev; 2019 Aug; 8(8):CD013047. PubMed ID: 31425631
[TBL] [Abstract][Full Text] [Related]
12. Neurocognitive, symptom, and health-related quality of life outcomes of a randomized trial of bevacizumab for newly diagnosed glioblastoma (NRG/RTOG 0825).
Wefel JS; Armstrong TS; Pugh SL; Gilbert MR; Wendland MM; Brachman DG; Roof KS; Brown PD; Crocker IR; Robins HI; Hunter G; Won M; Mehta MP
Neuro Oncol; 2021 Jul; 23(7):1125-1138. PubMed ID: 33515019
[TBL] [Abstract][Full Text] [Related]
13. Multidomain and long-term cognitive evaluation in malignant glioma patients.
Tanzilli A; Pace A; Prosperini L; Oppido PA; Telera S; Rasile F; Farneti A; Marucci L; Villani V
Future Oncol; 2022 May; 18(15):1839-1848. PubMed ID: 35196869
[TBL] [Abstract][Full Text] [Related]
14. Genetic modulation of longitudinal change in neurocognitive function among adult glioma patients.
Wefel JS; Zhou R; Sulman EP; Boehling NS; Armstrong GN; Tsavachidis S; Liang FW; Etzel CJ; Kahalley LS; Small BJ; Scheurer ME; Bondy ML; Liu Y
J Neurooncol; 2022 Jan; 156(1):185-193. PubMed ID: 34817796
[TBL] [Abstract][Full Text] [Related]
15. Neurocognitive impairment and patient-proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients.
Caramanna I; Klein M; van den Bent M; Idbaih A; Wick W; Taphoorn MJB; Dirven L; Bottomley A; Reijneveld JC;
Qual Life Res; 2022 Nov; 31(11):3253-3266. PubMed ID: 35982202
[TBL] [Abstract][Full Text] [Related]
16. Tumour and surgery effects on cognitive functioning in high-grade glioma patients.
Habets EJ; Kloet A; Walchenbach R; Vecht CJ; Klein M; Taphoorn MJ
Acta Neurochir (Wien); 2014 Aug; 156(8):1451-9. PubMed ID: 24879620
[TBL] [Abstract][Full Text] [Related]
17. Alterations in Functional Connectomics Associated With Neurocognitive Changes Following Glioma Resection.
Noll KR; Chen HS; Wefel JS; Kumar VA; Hou P; Ferguson SD; Rao G; Johnson JM; Schomer DF; Suki D; Prabhu SS; Liu HL
Neurosurgery; 2021 Feb; 88(3):544-551. PubMed ID: 33080024
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal study of cognitive function in glioma patients treated with modern radiotherapy techniques and standard chemotherapy.
Rydelius A; Lätt J; Kinhult S; Engelholm S; Van Westen D; Pihlsgård M; Bengzon J; Sundgren PC; Lilja Å
Acta Oncol; 2020 Sep; 59(9):1091-1097. PubMed ID: 32847475
[No Abstract] [Full Text] [Related]
19. Relationships between tumor grade and neurocognitive functioning in patients with glioma of the left temporal lobe prior to surgical resection.
Noll KR; Sullaway C; Ziu M; Weinberg JS; Wefel JS
Neuro Oncol; 2015 Apr; 17(4):580-7. PubMed ID: 25227126
[TBL] [Abstract][Full Text] [Related]
20. A research of preoperative neurocognitive functioning and contributing factors in patients with supratentorial gliomas.
Wang L; Fang S; Peng Y
Neurosci Lett; 2022 Apr; 775():136527. PubMed ID: 35167943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
